Variation among state-level approaches to addressing alcohol abuse in opioid treatment programs

Journal of Substance Abuse Treatment

Volumn 39, Issue 1, 2010, Pages 58-64

  Harris, Gavin H ^e   Strauss, Shiela M ^a   Katigbak, Carina ^a   Brar, Bhupinder S ^f   Brown, Lawrence S ^b   Kipnis, Steven S ^c   Kritz, Steven A ^b   Parrino, Mark W ^d  

^a NEW YORK UNIVERSITY   (United States)

^b Addiction Research and Treatment Corporation   (United States)

^c New York State Office of Alcoholism and Substance Abuse Services   (United States)

^d American Association for the Treatment of Opioid Dependence   (United States)

^e Downstate Health Sciences University   (United States)

^f NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

Author keywords

Alcohol addiction; Alcohol reduction support; Methadone maintenance; Opioid treatment program; State opioid treatment authority

Indexed keywords

ALCOHOL; METHADONE; OPIATE;

ALCOHOL ABUSE; ALCOHOLISM; ARTICLE; COUNSELING; DRUG DEPENDENCE TREATMENT; GOVERNMENT REGULATION; HEALTH CARE POLICY; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH SERVICE; HEALTH SURVEY; HUMAN; LICENSING; METHADONE TREATMENT; OPIATE ADDICTION; OPIOID TREATMENT PROGRAM; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL DELEGATION; TELECONSULTATION;

ALCOHOL DRINKING; ALCOHOL-RELATED DISORDERS; HEALTH POLICY; HUMANS; OPIOID-RELATED DISORDERS; PRACTICE GUIDELINES AS TOPIC; STATE GOVERNMENT; SUBSTANCE ABUSE TREATMENT CENTERS; TELEPHONE; UNITED STATES;

EID: 77953612094     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2010.03.010     Document Type: Article

References (41)

1. Batki S.L., Kauffman J.F., Marion I., Parrino M.W., & Woody G.E., (2005). Center for Substance Abuse Treatment (CSAT). Medication-assisted treatment for opioid addiction in opioid treatment programs. Rockville, MD: Substance Abuse and Mental Health Services Administration (SAMHSA); Treatment Improvement Protocol (TIP) 43.
2. Braithwaite R.S., McGinnis K.A., Conigliaro J., Maisto S.A., Crystal S., Day N., et al. A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. Alcoholism: Clinical and Experimental Research 2005, 29:1190-1197.
3. Chatham L.R., Rowan-Szal G.A., Joe G.W., Brown B.S., Simpson D.D. Heavy drinking in a population of methadone-maintained clients. Journal of Studies on Alcohol and Drugs 1995, 56:417-422.
4. Clark N.C., Dietze P., Lenne M.G., Redman J.R. Effect of opioid substitution therapy on alcohol metabolism. Journal of Substance Abuse Treatment 2006, 30:191-196.
5. Committee on Federal Regulation of Methadone Treatment Federal regulation of methadone treatment 1995, National Academies Press, Washington, DC.
6. Conigliaro J., Gordon A.J., McGinnis K.A., Rabeneck L., Justice A.C. How harmful is hazardous alcohol use and abuse in HIV infection: Do health care providers know who is at risk?. Journal of Acquired Immune Deficiency Syndromes 2003, 33:521-525.
7. Conigliaro J., Madenwald T., Bryant K., Braithwaite S., Gordon A., Fultz S., et al. The Veterans Aging Cohort Study: Observational studies of alcohol use, abuse, and outcomes among human immunodeficiency virus-infected veterans. Alcoholism: Clinical and Experimental Research 2004, 28:313-321.
8. Connors G.J., Carroll K.M., DiClemente C.C., Longabaugh R., Donovan D.M. The therapeutic alliance and its relationship to alcoholism treatment participation and outcome. Journal of Consulting and Clinical Psychology 1997, 65:588-598.
9. Cook R.T. Alcohol abuse, alcoholism, and damage to the immune system: A review. Alcoholism: Clinical and Experimental Research 1998, 22:1927-1942.
10. Corrao G., Arico S. Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis. Hepatology 1998, 27:914-919.
11. D'Aunno T., Pollack H.A. Changes in methadone treatment practices: Results from a national panel study, 1988-2000. Journal of the American Medical Association 2002, 288:850-856.
12. DeMaria P., Sterling R., Weinstein S. The effect of stimulant and sedative use on the treatment outcome of patients admitted to methadone maintenance treatment. American Journal on Addictions 2000, 9:145-153.
13. Donato F., Tagger A., Gelatti U., Parrinello G., Boffetta P., Albertini A., et al. Alcohol and hepatocellular carcinoma: The effect of lifetime intake and hepatitis virus infections in men and women. American Journal of Epidemiology 2002, 155:323-331.
14. Fiellin D.A., O'Connor P.G. New federal initiatives to enhance the medical treatment of opioid dependence. Annals of Internal Medicine 2002, 137:688-692.
15. Golin C.E., Liu H., Hays R.D., Miller L.G., Beck C.K., Ickovics J., et al. A prospective study of predictors of adherence to combination antiretroviral medication. Journal of General Internal Medicine 2002, 17:756-765.
16. Gossop M., Stewart D., Marsden J. Effectiveness of drug and alcohol counseling during methadone treatment: Content, frequency, and duration of counseling and association with substance use outcomes. Addiction 2005, 101:404-412.
17. Harris D.R., Gonin R., Alter H.J., Wright E.C., Buskell Z.J., Hollinger F.B., et al. The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse. Annals of Internal Medicine 2001, 134:120-124.
18. Hillebrand J., Marsden J., Finch E., Strang J. Excessive alcohol consumption and drinking expectations among clients in methadone maintenance. Journal of Substance Abuse Treatment 2001, 21:155-160.
19. Institute of Medicine Crossing the quality chasm: A new health system for the 21st century 2001, National Academy Press, Washington, DC.
20. Joe G.W., Simpson D.D., Broome K.M. Retention and patient engagement models for different treatment modalities in DATOS. Drug and Alcohol Dependence 1999, 57:113-125.
21. Kreek M.J. Drug interactions in humans related to drug abuse and its treatment. Modern Methods in Pharmacology 1990, 6:265-282.
22. Kubo S., Kinoshita H., Hirohashi K., Tanaka H., Tsukamoto T., Shuto T., et al. High malignancy of hepatocellular carcinoma in alcoholic patients with hepatitis C virus. Surgery 1997, 121:425-429.
23. Martin D.J., Garske J.P., Davis M.K. Relation of the therapeutic alliance with outcome and other related variables: A meta-analytic review. Journal of Consulting and Clinical Psychology 2000, 68:438-450.
24. Meier P., Barrowclough C., Donmall M.C. The role of the therapeutic alliance in the treatment of substance misuse: A critical review of the literature. Addiction 2005, 100:304-316.
25. Mintzer M., Stitzer M. Cognitive impairment in methadone maintenance patients. Drug and Alcohol Dependence 2002, 67:41-51.
26. Murphy D.A., Marelich W.D., Hoffman D., Steers W.N. Predictors of antiretroviral adherence. AIDS Care 2004, 16:471-484.
27. Ottomanelli G. Methadone patients and alcohol abuse. Journal of Substance Abuse Treatment 1999, 16:113-121.
28. Pacini M., Mellini A., Attilia M.L., Ceccanti M., Maremanni I. Alcohol abuse in heroin addicts: An unfolding metabolic destiny. Heroin Addiction & Related Clinical Problems 2005, 7:31-38.
29. Palepu A., Rajm A., Horton N.J., Tibbetts N., Meli S., Samet J.H. Substance abuse treatment and risk behaviors among HIV-infected persons with alcohol problems. Journal of Substance Abuse Treatment 2005, 28:3-9.
30. Parsons J.T., Vicioso K., Kutnick A., Punzalan J.C., Halkitis P.N., Velasquez M.M. Alcohol use and stigmatized sexual practices of HIV seropositive gay and bisexual men. Addictive Behaviors 2004, 29:1045-1051.
31. Pelletier L.R., Hoffman J.A. New federal regulations for improving quality in opioid treatment programs. Journal for Healthcare Quality 2001, 23:29-33.
32. Questionnaire Development System NOVA Research Company, Bethesda, MD Available online at. http://www.novaresearch.com/Products/qds/.
33. Rengade C.E., Kahn J.P., Schwan R. Misuse of alcohol among methadone patients. American Journal on Addictions 2009, 18:162-166.
34. Samet J.H., Horton N.J., Meli S., Freedberg K.A., Palepu A. Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcoholism: Clinical and Experimental Research 2004, 28:572-577.
35. Samet J.H., Horton N.J., Traphagen E.T., Lyon S.M., Freedberg K.A. Alcohol consumption and HIV disease progression: Are they related?. Alcoholism: Clinical and Experimental Research 2003, 27:862-867.
36. Senbanjo J., Wolff K., Marshall E.J. Excessive alcohol consumption is associated with reduced quality of life among methadone patients. Addiction 2006, 102:257-263.
37. Stein M., Herman D.S., Trisvan E., Pirraglia P., Engler P., Anderson B.J. Alcohol use and sexual risk behavior among human immunodeficiency virus-positive persons. Alcoholism: Clinical and Experimental Research 2005, 29:837-843.
38. Stenbacka M., Beck O., Leifman A., Romelsjo A., Helander A. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment. Drug and Alcohol Review 2007, 26:55-63.
39. Substance Abuse and Mental Health Services Administration SAMHSA Opioid treatment program accreditation Accessed on January 7, 2010 at. http://www.dpt.samhsa.gov/regulations/accreditation.aspx.
40. Westreich L.M. Alcohol and mental illness: Clinical focus. Primary Psychiatry 2005, 12:41-46.
41. Wiley T.E., McCarthy M., Breidi L., McCarthy M., Layden T.J. Impact of alcohol on the histological and clinical progression of hepatitis infection. Hepatology 1998, 28:805-809.